SCHEMBL28478495

SCHEMBL28478495

CCCCN(CCCC)CCNCc1ccc(OC(N)=O)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.40
OPRD1 P41143 4/20 0.40
OPRK1 P41145 4/20 0.40
CD274 Q9NZQ7 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
GRIN1 Q05586 1/20 0.39
KCNH2 Q12809 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
ROCK1 Q13464 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
CXCR4 P61073 1/20 0.38
S1PR1 P21453 6/20 0.37
S1PR3 Q99500 6/20 0.37
S1PR2 O95136 5/20 0.37
THRA P10827 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28482119 0.90 SMN1; SMN2 (0.44) OPRM1OPRD1OPRK1CD274GRIN2D
SCHEMBL28486270 0.82 OPRM1 (0.42) OPRM1OPRD1OPRK1CD274GRIN2D
SCHEMBL29798282 0.80 MAPT (0.42) CXCR4S1PR1S1PR3S1PR2S1PR4
SCHEMBL23327043 0.80 MAPT (0.42) CXCR4S1PR1S1PR3S1PR2S1PR4
SCHEMBL28486272 0.80 S1PR1 (0.42) OPRM1OPRD1OPRK1CD274GRIN2D
SCHEMBL21412738 0.77 KDM4E (0.43) CD274CXCR4S1PR1S1PR3S1PR2
SCHEMBL11115121 0.76 NFKB1 (0.55) THRATHRBKDM4EALDH1A1MAPT
SCHEMBL28486275 0.76 S1PR1 (0.38) OPRM1OPRD1OPRK1CD274GRIN2D
SCHEMBL28902265 0.74 SMN1; SMN2 (0.44) OPRM1OPRD1OPRK1CD274GRIN2D
SCHEMBL29798161 0.74 NAMPT (0.47) CD274GRIN2BCXCR4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111936466-A Compounds for the treatment of cardiac arrhythmias and heart failure 埃利克斯生物技术公司 2020-11-13 CN disclosed